 Isabelle Buard
Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 7 | 2023 | 599 | 2.610 |
Why?
| | Magnetoencephalography | 4 | 2025 | 161 | 1.790 |
Why?
| | Transcranial Magnetic Stimulation | 4 | 2020 | 66 | 1.730 |
Why?
| | Music Therapy | 2 | 2025 | 24 | 1.550 |
Why?
| | Cognitive Dysfunction | 3 | 2023 | 467 | 1.060 |
Why?
| | Motor Skills | 2 | 2025 | 104 | 0.990 |
Why?
| | Neurological Rehabilitation | 1 | 2025 | 13 | 0.890 |
Why?
| | Huntington Disease | 1 | 2025 | 61 | 0.840 |
Why?
| | Neuroglia | 4 | 2014 | 173 | 0.780 |
Why?
| | Tremor | 1 | 2022 | 98 | 0.700 |
Why?
| | Purkinje Cells | 2 | 2014 | 65 | 0.690 |
Why?
| | Agnosia | 1 | 2021 | 2 | 0.690 |
Why?
| | Synapses | 5 | 2014 | 439 | 0.690 |
Why?
| | Motor Disorders | 1 | 2021 | 17 | 0.680 |
Why?
| | Brain Waves | 1 | 2021 | 45 | 0.680 |
Why?
| | Parietal Lobe | 1 | 2021 | 61 | 0.670 |
Why?
| | Temporal Lobe | 1 | 2021 | 105 | 0.650 |
Why?
| | Connectome | 1 | 2021 | 93 | 0.650 |
Why?
| | Travel-Related Illness | 1 | 2020 | 5 | 0.640 |
Why?
| | Nerve Net | 1 | 2021 | 284 | 0.540 |
Why?
| | Psychomotor Performance | 1 | 2019 | 324 | 0.480 |
Why?
| | Neurons | 5 | 2014 | 1649 | 0.460 |
Why?
| | Cerebellum | 2 | 2014 | 224 | 0.430 |
Why?
| | Alzheimer Disease | 1 | 2021 | 630 | 0.430 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2014 | 196 | 0.410 |
Why?
| | Disease Progression | 1 | 2021 | 2864 | 0.400 |
Why?
| | Cognition Disorders | 1 | 2017 | 541 | 0.390 |
Why?
| | Basal Ganglia | 2 | 2023 | 57 | 0.330 |
Why?
| | Proteins | 2 | 2014 | 1023 | 0.320 |
Why?
| | Dendrites | 1 | 2010 | 104 | 0.290 |
Why?
| | Brain Mapping | 3 | 2021 | 538 | 0.280 |
Why?
| | Long-Term Potentiation | 1 | 2010 | 199 | 0.270 |
Why?
| | Memory | 1 | 2010 | 295 | 0.260 |
Why?
| | Patch-Clamp Techniques | 3 | 2014 | 289 | 0.240 |
Why?
| | Proof of Concept Study | 1 | 2025 | 89 | 0.220 |
Why?
| | Magnetic Resonance Imaging | 4 | 2023 | 3904 | 0.210 |
Why?
| | Hippocampus | 3 | 2023 | 971 | 0.190 |
Why?
| | Atrophy | 1 | 2023 | 199 | 0.180 |
Why?
| | Humans | 14 | 2025 | 145474 | 0.180 |
Why?
| | Mice, Inbred BALB C | 4 | 2014 | 1261 | 0.180 |
Why?
| | Fingers | 1 | 2022 | 107 | 0.170 |
Why?
| | Coculture Techniques | 2 | 2014 | 247 | 0.170 |
Why?
| | Electric Stimulation | 2 | 2014 | 276 | 0.170 |
Why?
| | Parkinsonian Disorders | 1 | 2021 | 43 | 0.170 |
Why?
| | Microtubule-Associated Proteins | 2 | 2014 | 194 | 0.170 |
Why?
| | Acoustic Stimulation | 2 | 2019 | 333 | 0.160 |
Why?
| | Animals, Newborn | 3 | 2014 | 891 | 0.160 |
Why?
| | Recovery of Function | 1 | 2025 | 716 | 0.160 |
Why?
| | Feasibility Studies | 1 | 2025 | 1111 | 0.160 |
Why?
| | Periodicity | 1 | 2019 | 58 | 0.150 |
Why?
| | Neuroimaging | 1 | 2021 | 297 | 0.140 |
Why?
| | Gait | 1 | 2021 | 312 | 0.140 |
Why?
| | Neuropsychological Tests | 1 | 2023 | 1134 | 0.130 |
Why?
| | Male | 8 | 2025 | 72842 | 0.130 |
Why?
| | Neural Pathways | 1 | 2018 | 313 | 0.120 |
Why?
| | Calmodulin | 2 | 2014 | 70 | 0.120 |
Why?
| | Vision Disorders | 1 | 2018 | 179 | 0.120 |
Why?
| | Cholesterol | 3 | 2014 | 408 | 0.120 |
Why?
| | Cues | 1 | 2018 | 327 | 0.120 |
Why?
| | Central Nervous System Diseases | 1 | 2017 | 74 | 0.120 |
Why?
| | Calcium | 2 | 2014 | 1190 | 0.120 |
Why?
| | Cells, Cultured | 3 | 2014 | 4148 | 0.120 |
Why?
| | Excitatory Postsynaptic Potentials | 3 | 2014 | 119 | 0.110 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1747 | 0.110 |
Why?
| | Models, Biological | 1 | 2021 | 1764 | 0.100 |
Why?
| | Adult | 3 | 2025 | 40777 | 0.100 |
Why?
| | Action Potentials | 2 | 2014 | 502 | 0.100 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2014 | 47 | 0.100 |
Why?
| | Biophysics | 1 | 2014 | 75 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2014 | 456 | 0.100 |
Why?
| | Middle Aged | 4 | 2025 | 36215 | 0.100 |
Why?
| | Patient Safety | 1 | 2017 | 356 | 0.090 |
Why?
| | Culture Media, Conditioned | 2 | 2010 | 112 | 0.090 |
Why?
| | Phosphorylation | 3 | 2014 | 1707 | 0.090 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1789 | 0.090 |
Why?
| | Aged, 80 and over | 2 | 2021 | 8333 | 0.090 |
Why?
| | Female | 5 | 2025 | 78844 | 0.090 |
Why?
| | Mice | 5 | 2014 | 18329 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2019 | 3623 | 0.090 |
Why?
| | Benzylamines | 1 | 2010 | 44 | 0.080 |
Why?
| | Viral Fusion Proteins | 1 | 2010 | 21 | 0.080 |
Why?
| | Thy-1 Antigens | 1 | 2010 | 11 | 0.080 |
Why?
| | Cell-Penetrating Peptides | 1 | 2010 | 21 | 0.080 |
Why?
| | Cognition | 1 | 2018 | 1266 | 0.080 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2010 | 41 | 0.080 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5904 | 0.080 |
Why?
| | Rats | 4 | 2014 | 5584 | 0.080 |
Why?
| | Glutamate Decarboxylase | 1 | 2010 | 165 | 0.070 |
Why?
| | Animals | 8 | 2014 | 38030 | 0.070 |
Why?
| | Conditioning, Classical | 1 | 2010 | 119 | 0.070 |
Why?
| | Neural Inhibition | 1 | 2010 | 178 | 0.070 |
Why?
| | Mice, Transgenic | 1 | 2014 | 2188 | 0.070 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1048 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 1 | 2010 | 666 | 0.060 |
Why?
| | Macular Degeneration | 1 | 2009 | 191 | 0.060 |
Why?
| | Retina | 1 | 2009 | 326 | 0.060 |
Why?
| | Behavior, Animal | 1 | 2010 | 519 | 0.060 |
Why?
| | Aged | 3 | 2021 | 26153 | 0.060 |
Why?
| | Peptide Fragments | 1 | 2010 | 693 | 0.060 |
Why?
| | Sulfonamides | 1 | 2010 | 583 | 0.060 |
Why?
| | Carrier Proteins | 1 | 2010 | 728 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 2028 | 0.060 |
Why?
| | Treatment Outcome | 1 | 2020 | 11772 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 1 | 2010 | 2524 | 0.050 |
Why?
| | Protein Kinase Inhibitors | 1 | 2010 | 981 | 0.050 |
Why?
| | Behavior | 1 | 2018 | 89 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2007 | 2597 | 0.030 |
Why?
| | Computational Biology | 1 | 2021 | 669 | 0.030 |
Why?
| | Child | 1 | 2017 | 22707 | 0.030 |
Why?
| | Protein Binding | 2 | 2014 | 2238 | 0.030 |
Why?
| | Miniature Postsynaptic Potentials | 1 | 2014 | 10 | 0.030 |
Why?
| | Brain | 1 | 2006 | 2947 | 0.030 |
Why?
| | Algorithms | 1 | 2021 | 1845 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2014 | 277 | 0.020 |
Why?
| | Point Mutation | 1 | 2014 | 240 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2014 | 762 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2014 | 407 | 0.020 |
Why?
| | RNA Interference | 1 | 2014 | 475 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2014 | 335 | 0.020 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 228 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 637 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2014 | 471 | 0.020 |
Why?
| | PC12 Cells | 1 | 2010 | 42 | 0.020 |
Why?
| | Niemann-Pick Disease, Type C | 1 | 2009 | 2 | 0.020 |
Why?
| | Electroretinography | 1 | 2009 | 50 | 0.020 |
Why?
| | Nerve Degeneration | 1 | 2009 | 49 | 0.020 |
Why?
| | Phagosomes | 1 | 2009 | 40 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2010 | 387 | 0.020 |
Why?
| | Filipin | 1 | 2007 | 4 | 0.020 |
Why?
| | Heme Oxygenase (Decyclizing) | 1 | 2007 | 21 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2010 | 500 | 0.020 |
Why?
| | Electrophysiology | 1 | 2007 | 218 | 0.020 |
Why?
| | Autophagy | 1 | 2009 | 291 | 0.020 |
Why?
| | Kinetics | 1 | 2010 | 1567 | 0.020 |
Why?
| | Retinal Ganglion Cells | 1 | 2007 | 121 | 0.010 |
Why?
| | Extracellular Matrix Proteins | 1 | 2007 | 156 | 0.010 |
Why?
| | Rats, Wistar | 1 | 2007 | 450 | 0.010 |
Why?
| | Calcium-Binding Proteins | 1 | 2007 | 221 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 977 | 0.010 |
Why?
| | Blotting, Western | 1 | 2007 | 1179 | 0.010 |
Why?
| | Cell Line | 1 | 2010 | 2823 | 0.010 |
Why?
| | Fatty Acids | 1 | 2007 | 457 | 0.010 |
Why?
| | Peptides | 1 | 2010 | 998 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1716 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2009 | 3124 | 0.010 |
Why?
| | RNA | 1 | 2007 | 910 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2007 | 2046 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2006 | 2507 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 2007 | 1923 | 0.010 |
Why?
| | Signal Transduction | 1 | 2010 | 5216 | 0.010 |
Why?
|
|
Buard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|